Citation Impact
Citing Papers
TFEB Links Autophagy to Lysosomal Biogenesis
2011 StandoutScience
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
2013 StandoutScience
Identification of a Tumor Suppressor Relay between the FOXP3 and the Hippo Pathways in Breast and Prostate Cancers
2011
A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF Inhibition
2013
Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice
2007 StandoutNobel
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
2009 StandoutScience
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
2010 StandoutScienceNobel
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
2005 StandoutNobel
Elevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma
2008
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
CD4+ Tregs and immune control
2004 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
The Drosophila RASSF Homolog Antagonizes the Hippo Pathway
2006
Rassf Family of Tumor Suppressor Polypeptides
2008
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
2010
Coordinating ERK/MAPK signalling through scaffolds and inhibitors
2005 Standout
A view on drug resistance in cancer
2019 StandoutNature
A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors
2013 Standout
Tumor adaptation and resistance to RAF inhibitors
2013
Forces in Tissue Morphogenesis and Patterning
2013 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
2008
Molecular pathogenesis of Parkinson disease: insights from genetic studies
2009
Raf‐1 kinase associates with Hepatitis C virus NS5A and regulates viral replication
2005
Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila
2012
CNK1 Is a Scaffold Protein That Regulates Src-mediated Raf-1 Activation
2005
Yes-associated protein (YAP) functions as a tumor suppressor in breast
2008
A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology
2008 Standout
The pro‐apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1
2007
Integration of Proteomics and Genomics in Platelets
2003
The Emerging Role of the Hippo Pathway in Cell Contact Inhibition, Organ Size Control, and Cancer Development in Mammals
2008
Deciphering the role of heterozygous mutations in genes associated with parkinsonism
2007
The DeMSTification of Mammalian Ste20 Kinases
2009
Clk post-transcriptional control denoises circadian transcription both temporally and spatially
2015 StandoutNobel
Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila
2007
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
2010 StandoutNature
Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP)
2008
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
2015 Standout
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
2011 StandoutNature
A dimerization-dependent mechanism drives RAF catalytic activation
2009 Nature
Mapping the platelet proteome: a report of the ISTH Platelet Physiology Subcommittee
2005
MAP kinase signalling pathways in cancer
2007 Standout
What causes cell death in Parkinson's disease?
2009
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
C-Raf Inhibits MAPK Activation and Transformation by B-RafV600E
2009
The Hippo Signaling Pathway in Development and Cancer
2010 Standout
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
2010 Nature
Platelet Activation and Atherothrombosis
2007 Standout
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
2006
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Parkinson's disease
2015 Standout
The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development
2008
A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis
2014
The Hippo pathway: regulators and regulations
2013
Modulating F‐actin organization induces organ growth by affecting the Hippo pathway
2011
Phosphorylation of BRAF by AMPK Impairs BRAF-KSR1 Association and Cell Proliferation
2013
Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate
2007
Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts
2013
NDR Kinase Is Activated by RASSF1A/MST1 in Response to Fas Receptor Stimulation and Promotes Apoptosis
2008
The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
2007
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Wild-Type and Mutant B-RAF Activate C-RAF through Distinct Mechanisms Involving Heterodimerization
2005
Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
2009
Platelet genomics and proteomics in human health and disease
2005
Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C‐terminal coiled‐coil domains, leads to its stabilization and phosphorylation
2006
A Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life Span
2006
AKT/PKB Signaling: Navigating the Network
2017 Standout
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Dynamics of the Ras/ERK MAPK Cascade as Monitored by Fluorescent Probes
2006
The PI3K Pathway in Human Disease
2017 Standout
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
2008 StandoutNature
A crucial role of WW45 in developing epithelial tissues in the mouse
2008
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
2011
Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals
2007 Standout
Role of YAP/TAZ in mechanotransduction
2011 StandoutNature
YAP regulates neural progenitor cell number via the TEA domain transcription factor
2008
The RASSF proteins in cancer; from epigenetic silencing to functional characterization
2009
Identification of 14-3-3ε Substrates from Embryonic Murine Brain
2006
Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes
2011
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Reduction in Raf Kinase Inhibitor Protein Expression Is Associated with Increased Ras-Extracellular Signal-Regulated Kinase Signaling in Melanoma Cell Lines
2004
CD4+CD25−LAG3+regulatory T cells controlled by the transcription factor Egr-2
2009 StandoutNobel
Immuno-Navigator, a batch-corrected coexpression database, reveals cell type-specific gene networks in the immune system
2016 StandoutNobel
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
2012 StandoutNobel
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
2011
A role for Dicer in immune regulation
2006 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway
2008
A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase Signaling
2012
Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells
2003 StandoutNobel
Hippo Pathway–Dependent and –Independent Roles of RASSF6
2009
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
2017 Standout
Strong negative feedback from Erk to Raf confers robustness to MAPK signalling
2011
Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila
2011
Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells
2005 StandoutNobel
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
2007 StandoutScience
Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway.
2015
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
PLX4032, a selective BRAF V600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF WT melanoma cells
2010
CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes
2004 StandoutNobel
LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
2010
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Hippo pathway regulation by cell morphology and stress fibers
2011
Structural basis for reversible photoswitching in Dronpa
2007 StandoutNobel
Raf-1 sets the threshold of Fas sensitivity by modulating Rok-α signaling
2005
Hippo signaling: growth control and beyond
2010
Works of Eric O’Neill being referenced
Regulation and Role of Raf-1/B-Raf Heterodimerization
2006
Role of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1
2004 Science
Clinical utility of RASSF1A methylation in human malignancies
2015
Conferring specificity on the ubiquitous Raf/MEK signalling pathway
2004
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
2005
RASSF1A Elicits Apoptosis through an MST2 Pathway Directing Proapoptotic Transcription by the p73 Tumor Suppressor Protein
2007
A Hippo in the ointment: MST signalling beyond the fly
2008
ATM Regulates a RASSF1A-Dependent DNA Damage Response
2009
MST Kinases Monitor Actin Cytoskeletal Integrity and Signal via c-Jun N-Terminal Kinase Stress-Activated Kinase To Regulate p21Waf1/Cip1 Stability
2009
Towards complete analysis of the platelet proteome
2002
Mammalian Sterile 20–Like Kinases in Tumor Suppression: An Emerging Pathway
2005
Taming the Hippo: Raf-1 Controls Apoptosis by Suppressing MST2/Hippo
2005